Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Intestinal intraepithelial lymphocytes are crucial for gut immunity and maintaining the mucosal barrier.

Mesenchymal stromal cell therapies show promise for treating various diseases but need more research and standardization.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Combination therapies might work better for some vitiligo patients, but results vary.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

A new mouse model for vitiligo helps study immune responses and potential treatments.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

JAK inhibitors help hair growth by boosting beta-catenin activity in hair root cells.

Inhibiting TYK2 can restore hair growth in alopecia areata.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Hair follicle cells help protect against immune attacks by regulating T-cell activity.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Tenofovir is more effective than adefovir for resistant hepatitis B, Fibroscan is good for assessing liver damage, regulatory T cells may help hepatitis C persist, and other insights into liver health and disease were found.

Lichen planopilaris may be an autoimmune disease causing hair loss due to immune system issues in hair follicles.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

The document concludes that computational models are useful for understanding immune responses and could improve cancer immunotherapy.

Permanent hair dye may cause total hair loss.

Inflammasome proteins can indicate the severity and treatment response of various diseases and injuries.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

Understanding how hair follicle stem cells work can help find new ways to prevent hair loss and promote hair growth.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Regenerative therapies show promise for treating vitiligo and alopecia areata.